EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Representation of Surgery in Registered Clinical Trials for Brain Metastases: An Analysis of the ClinicalTrials.gov Database

Sandra Leskinen, Nathan A Shlobin, Roland A Scott iD, Hannah Haile, Mommina Ashaque, Brian J A Gill

Cancers · 31.10.2026 · 18 (21) · 3507

DOI: 10.3390/cancers18213507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 31.10.2026. Verfasst von Sandra Leskinen und 5 weiteren Autor:innen. Beteiligte Einrichtung: State University of New York Downstate College of Medicine, 445 Lenox Rd, Brooklyn, NY 11203, USA. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Brain metastases (BMs) represent a significant clinical challenge affecting 10–26% of patients who die from cancer. While surgery plays an established role in the management of selected patients, its representation within the registered clinical trial landscape has not been systematically characterized.

Methods

In this cross-sectional registry analysis, ClinicalTrials.gov was searched on 20 December 2025, using condition terms related to BMs combined with the Boolean operator OR. Interventional and observational studies were included without restrictions on phase, status, sex, or age; trials not updated since 1 January 2015 were excluded. Included studies were classified as surgery-focused, surgery-enabled, or non-surgical. Data were extracted on study characteristics, interventions, and outcomes.

Results

A total of 493 trials were included. Of these, 57 (11.6%) involved surgery, including 9 (1.8%) surgery-focused and 48 (9.7%) surgery-enabled trials, whereas 436 (88.4%) were non-surgical. Radiotherapy was the dominant treatment platform, present in 262 trials (53.1%), with stereotactic radiosurgery reported in 179 (36.3%). Among the 57 surgical trials, the most common primary endpoint categories were periprocedural/safety and local control outcomes (each 26/57, 45.6%) and survival (20/57, 35.1%). Only 4 surgical trials (7.0%), all surgery-focused, had a primary endpoint that directly measured an operative outcome.

Conclusions

Surgery accounted for a minority of registered brain metastasis trials and more commonly served as context for evaluating adjuvant, radiation-based, and multimodality approaches than as the primary intervention under study. Surgical trials were weighted toward safety, local control, and survival endpoints, with less frequent emphasis on surgery-specific and functional outcomes.

Schlagwörter

Stichwörter der Autor:innen

ClinicalTrials.govbrain metastasesbrain tumorclinical trialsneuro-oncologyneurosurgeryradiotherapy

Autor:innen und Institutionen

  • State University of New York Downstate College of Medicine, 445 Lenox Rd, Brooklyn, NY 11203, USA.
  • Department of Neurosurgery, The Neurological Institute of New York, Columbia University Irving Medical Center, 710 W 168th St, New York, NY 10032, USA.

ORCID-Profile: Roland A Scott

Zitieren

APA

Leskinen, S., Shlobin, N. A., Scott, R. A., Haile, H., Ashaque, M., & Gill, B. J. A. (2026). Representation of Surgery in Registered Clinical Trials for Brain Metastases: An Analysis of the ClinicalTrials.gov Database. Cancers, 18(21), 3507. https://doi.org/10.3390/cancers18213507

Vancouver

Leskinen S, Shlobin NA, Scott RA, Haile H, Ashaque M, Gill BJA. Representation of Surgery in Registered Clinical Trials for Brain Metastases: An Analysis of the ClinicalTrials.gov Database. Cancers. 2026;18(21):3507. doi:10.3390/cancers18213507

BibTeX
@article{Leskinen2026,
  author = {Leskinen, Sandra and Shlobin, Nathan A and Scott, Roland A and Haile, Hannah and Ashaque, Mommina and Gill, Brian J A},
  title = {Representation of Surgery in Registered Clinical Trials for Brain Metastases: An Analysis of the ClinicalTrials.gov Database},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {21},
  pages = {3507},
  doi = {10.3390/cancers18213507}
}
Kostenlos starten →